Hosted on MSN11mon
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's DataCoding Test score at Day 42. WAIS-IV is the most advanced adult measure of cognitive ability. Dalzanemdor (SAGE-718) was generally well-tolerated, and no new safety signals were observed.
The LIGHTWAVE study, a 12-week, randomized, double-blind, placebo-controlled trial, aimed to assess improvements in cognitive function using the Wechsler Adult Intelligence Scale Fourth Edition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results